Publikationsliste Reinhard Büttner Original papers 1989-2017 (1) Handt S., R. Büttner, R. Knüchel, H. Rübben, F. Hofstädter, and C. Wagener: Investigations for a point mutation in the c-Ha-ras 1 oncogene in the genome of bladdercarcinomas by Southern blot analysis. Invest. Urolog. 3: 125-128 (1989). (2) Buettner R., S. Yim, Y. Hong, E. Boncinelli, and M.A. Tainsky: Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cell. Mol. Cell. Biol. 11: 3573-3583 (1991). (3) Tainsky M.A., S. Yim, D.B. Krizman, P. Kannan, P. Chiao, T. Mukhopadhyay, and R. Buettner: Modulation of differentiation in PA-1 human teratocarcinoma cells by an N-ras oncogene. Oncogene 6: 1575-1582 (1991). (4) Kannan P., R. Buettner, D.R. Pratt, and M.A. Tainsky: Identification of a retinoic acid inducible endogenous retrovirus in the human teratocarcinoma-derived cell line PA-1. J. Virol. 65: 6343-6348 (1991). (5) Le-Ruppert K., J.R.W. Masters, R. Knuechel, S. Seegers, M.A. Tainsky, F. Hofstaedter, and R. Buettner: The effect of retinoic acid on chemosensitivity of PA-1 human teratocarcinoma cells and its modulation by an activated N-ras oncogene. Int. J. Cancer 51: 646-651 (1992). (6) Meyer S., R. Buettner, P. Sauer und L. Rupprecht: Akuter arterieller Extremitätenverschluß durch Tumorembolus (Case report and review of literature). Der Chirurg 64: 424-26 (1993). (7) Rohrer L., F.Raulf, C.Bruns, F. Hofstaedter, R. Buettner and R Schuele: Cloning and characterization of a fourth human somatostatin receptor. Proc. Natl. Acad. Sci. USA 90: 4196-4200 (1993). (8) R. Buettner, R. Bauer, A. Imhof, M.A. Tainsky und F. Hofstaedter: AP-2: a nuclear effector of malignant transformation by ras-oncogenes. Verh. Dtsch. Ges. Pathol. 77: 271-275 (1993). (9) Buettner R., P. Kannan, A. Imhof, R. Bauer, S.O. Yim, R. Glockshuber, M.W. Van Dyke, and M.A. Tainsky: An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol. Cell. Biol. 13: 4174-4185 (1993). (10) Moser M., A. Pscherer, R. Bauer, A. Imhof, S.Seegers, M. Kerscher and R. Buettner: The complete murine cDNA sequence of the transcription factor AP-2. Nucl. Acids Res. 21: 4844 (1993). (11) Kopp H., J.R. Masters, W. Wieland, F. Hofstaedter und R. Buettner: Differential regulation of androgen receptor promoter in hormone-sensitive and -insensitive prostate carcinoma cells. Verh. Dtsch. Ges. Pathol. 77: 129-133 (1993). (12) Rüschoff J., T. Bocker, R. Buettner, A. Bittinger, W. Wieland und F. Hofstädter: In vitro und ex vivo expression of nuclear proliferation-associated antigens (p120, B23) in the prostate. Verh. Dtsch. Ges. Pathol. 77: 103-106 (1993). (13) Dermietzel R., T.K. Hwang, R. Buettner, A. Hofer, E. Dotzler, M. Kremer, F.P. Thinnes, D. Siemen: Cloning of a brain-derived porin and its in situ identification in astrocytic plasma membranes. Proc. Natl. Acad. Sci. USA 91: 499-503 (1994). (14) Kannan P., R. Buettner, P.J. Chiao, S.O. Yim, M. Sarkiss and M.A. Tainsky: N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev. 8: 1258-1269 (1994). (15) Schuster U., R. Buettner, F. Hofstaedter, R. Knuechel: An in vitro coculture system to study interaction between bladder cancer cells and stromal cells. J. Urol. 151: 1707-1711 (1994). (16) Bauer R., A. Pscherer, A. Imhof, M. Moser, S. Seegers, M.A. Tainsky, F. Hofstaedter and R. Buettner: The genomic structure of the human gene coding for the transcription factor AP-2. Nucl. Acids Res. 22: 1413-1420 (1994). (17) Buettner R., M. Moser, A. Pscherer, A. Imhof, R. Bauer, F. Hofstädter: Molecular cloning of a novel AP-2 transcription factor, AP-2ß, and its function in cell differentiation. Verh. Dtsch. Ges. Pathol. 78: 38-42 (1994). (18) Blesch A., A.K. Boßerhoff, R. Apfel, C. Behl, B. Heßdörfer, A. Schmitt, P. Jachimczak, F. Lottspeich, R. Buettner and U. Bogdahn: Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res. 54: 5695-5701 (1994). (19) Bocker T., A. Bittinger, W. Wieland, R. Buettner, G. Fauser, F. Hofstädter and J. Rüschoff: In vitro and ex vivo expression of nucleolar proteins (B23, p120) in benign and malignant epithelial lesions of the prostate. Mod. Pathol. 8: 226-231 (1995). (20) Jacob K., A.K. Boßerhoff, F. Wach, R. Knüchel, R. Hein, and R. Buettner: Selection of high- and low- invasive sublines of a primary melanoma cell line and isolation of subtractive cDNA clones. Int. J. Cancer 60: 668- 675 (1995). (21) Messmann H., S. Hollerbach, V. Gross, A. Holstege, R. Büttner, J. Schmidt, W. Hohenberger und J. Schölmerich: Multiple Magenwandabszesse - eine seltene endosonographische Differentialdiagnose submuköser Magentumoren. Z. Gastroenterol. 33: 170-172 (1995). (22) Moser M., A. Pscherer, A. Imhof, R. Bauer, M. Kerscher, W. Amselgruber, F. Sinowatz, F. Hofstaedter, R. Schüle and R. Buettner: Molecular cloning and characterization of a second AP-2 transcription activator gene, AP- 2ß. Development 121: 2779-2788 (1995). (23) Gaubatz S., A. Imhof, R. Dosch, O. Werner, P. Mitchell, R. Buettner and M. Eilers: Transcription factor AP-2 negatively regulates gene activation by myc. EMBO J. 14: 1508-1519 (1995). (24) Boßerhoff A.K., R. Hein, U. Bogdahn and R. Buettner: Structure and promoter analysis of the human MIA gene. J. Biol. Chem. 271: 490-495 (1996). (25) Buettner R., B. Schleicher, P. Schleicher, J. Rüschoff and F. Hofstädter: The benign placental site nodule: Case report and review of diseases of the intermediate trophoblast. Geburtsh. Frauenheilk. 56: 257-261 (1996). (26) Smith C.M., S.A. Ballard, N. Worman, R. Buettner, J.R.W. Masters: 5a-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro. J. Clin. Endocrin. Metab. 81: 1361-1366 (1996). (27) Pscherer A., U. Dörflinger, J. Kirfel, K. Gawlas, J. Rüschoff, R. Buettner and R. Schüle: The helix-loop- helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J. 15: 6680-6690 (1996). (28) Koehler M.R., A.K. Boßerhoff, G. von Beust, A. Bauer, A. Blesch, R. Buettner, J. Schlegel, U. Bogdahn, M. Schmid: Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-13.33 by flourescence in situ hybridization (FISH). Genomics 35: 265-267 (1996). (29) Moser M., J. Rüschoff and R. Buettner: Comparative analysis of AP-2 gene expression during murine embryogenesis. Dev. Dynam. 208: 115-124 (1997). (30) Bosserhoff A.K., S. Kondo, M. Moser, U.H. Dietz, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, R. Buettner and L. Sandell: Expression, structure and chromosomal localization of the mouse MIA/CD-RAP gene. Dev. Dynam. 208: 516-525 (1997). (31) Dammer, R., J. Stavenow, P. Held, J. Schröder, H. Niederdellmann, F. Hofstädter and R. Buettner: Pigmented Schwannoma of the oral cavity. Oral Surg., Oral Med., Oral Pathol., Oral Radiol. Endodont. 84: 40- 44 (1997). (32) Bogenrieder, T., D.P. Griese, R. Schiffner, R. Buettner, G.A. Riegger, U. Hohenleutner and M. Landthaler: Well's syndrome associated with idiopathic hypereosinophilic syndrome. Br. J. Dermatol. 137: 978-982 (1997). (33) Moser, M., A. Pscherer, C. Roth, J. Becker, G. Mücher, K. Zerres, C. Dixkens, J. Weis, L. Guay-Woodford, R. Buettner and R. Fässler: Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2ß. Genes Dev. 11: 1938-1948 (1997). (34) Bosserhoff A.K., M. Kaufmann, B. Kaluza, I. Bartke, H. Zirngibl, R. Hein, W. Stolz and R. Buettner: MIA, a novel serum marker for progression of malignant melanoma. Cancer Res. 57: 3149-3153 (1997). (35) Bosserhoff, A.K., A. Gläßl, W. Stolz and R. Buettner: Detection of telomerase activity in skin, melanocytic nevi and melanoma by telomerase PCR ELISA. BM Biochemica 3: 16-18 (1997). (36) Grether-Beck, S., R. Buettner and J. Krutmann: Ultraviolet A radiation-induced expression of human genes: molecular and photobiological mechanisms. Biol. Chem. 378: 1231-1236 (1997). (37) Jacob K., F. Wach, U. Holzapfel, R. Hein, E. Lengyel, R. Buettner and A.K. Bosserhoff: In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res. 8: 1-9 (1998). (38) Mücher G., J. Becker, M. Knapp, R. Buettner, M. Moser, S. Rudnik-Schöneborn, S. Somlo, G. Germino, L. Onuchic, E. Avner, L. Guay-Woodford, and K. Zerres: Fine mapping of the autosomal recessive polycystic kidney disease locus (PKHD1) and the genes MUT, RDS, CSNK2ß, and GSTA1 at 6p21.1-p12. Genomics 48: 40-45 (1998). (39) Kroiss, M.M., A.K. Bosserhoff, T. Vogt, R. Buettner, T. Bogenrieder, M. Landthaler and W. Stolz: Loss of expression or mutation in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanoma. Melanoma Res. 8: 504-509 (1998). (40) Bosserhoff, A.K., M. Lederer, M. Kaufmann, R. Hein, W. Stolz, R. Apfel, U. Bogdahn and R. Buettner: MIA, a novel serum marker for progression of malignant melanoma. Anticancer Res. 19: 2691-3 (1999). (41) Imhof A., M. Schuierer, O. Werner, M. Moser, C. Roth, R. Bauer and R. Buettner: Transcriptional regulation of the AP-2a promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor Mol. Cell. Biol. 19: 194-204 (1999). (42) Bosserhoff, A.K., M. Moser, R. Hein, M. Landthaler and R. Buettner: In situ expression patterns of melanoma-inhibiting activity (MIA) in malignant melanomas and breast cancers. J. Pathol. 187: 446-454 (1999). (43) Dörflinger, U., A. Pscherer, M. Moser, P. Rümmele, R. Schüle and R. Buettner: SSTR-2 expression in embryonic and adult tissues involves transcriptional activation by mib-1.